Methods for treatment of stroke or cerebrovascular accidents using an ETB receptor agonist
AssigneeMidwestern University
InventorAnil Gulati
Life of this patent
Estimating the term…
Abstract
Methods of using an ETB receptor agonist, such as IRL-1620, for the treatment of stroke or cerebrovascular accidents are disclosed. The ETB receptor agonist is used alone or in combination with a second agent useful in the treatment of stroke or other cerebrovascular accident.
Claims18
A method of reducing damage to a brain cell caused by lack of blood supply or lack of oxygenation to the brain cell comprising administering a therapeutically effective amount of N-Succinyl-[Glu9, Ala11,15] Endothelin 1 to an individual in need thereof, wherein the administering comprises multiple dose administration of N-Succinyl-[Glu9, Ala11,15] Endothelin 1.
Dependencies are inferred from the claim text.